These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4378682)

  • 41. Interconversion of the multiple forms of dihydrofolate reductase from amethopterin-resistant Lactobacillus casei.
    Dunlap RB; Gundersen LE; Huennekens FM
    Biochem Biophys Res Commun; 1971 Mar; 42(5):772-7. PubMed ID: 4396800
    [No Abstract]   [Full Text] [Related]  

  • 42. Dihydrofolate reductase of Streptococcus faecalis. I. Purification and some properties of reductase from the wild strain and from strain A.
    Hillcoat BL; Blakley RL
    J Biol Chem; 1966 Jul; 241(13):2995-3001. PubMed ID: 4957970
    [No Abstract]   [Full Text] [Related]  

  • 43. An isotopic assay for dihydrofolate reductase.
    Roberts D
    Biochemistry; 1966 Nov; 5(11):3549-51. PubMed ID: 4382039
    [No Abstract]   [Full Text] [Related]  

  • 44. The "induction" of leukocyte and erythrocyte dihydrofolate reductase by methotrexate. II. Clinical and pharmacologic studies.
    Bertino JR; Cashmore A; Fink M; Calabresi P; Lefkowitz E
    Clin Pharmacol Ther; 1965; 6(6):763-70. PubMed ID: 5846409
    [No Abstract]   [Full Text] [Related]  

  • 45. Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.
    Jackson RC; Niethammer D
    Eur J Cancer (1965); 1977 Jun; 13(6):567-75. PubMed ID: 880964
    [No Abstract]   [Full Text] [Related]  

  • 46. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
    Williams JW; Morrison JF; Duggleby RG
    Biochemistry; 1979 Jun; 18(12):2567-73. PubMed ID: 36135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate-resistant human promyelocytic leukemia (HL-60) cells express a dihydrofolate reductase with altered properties associated with increased enzyme activity.
    Dedhar S; Goldie JH
    Biochem Biophys Res Commun; 1985 Jun; 129(2):536-45. PubMed ID: 3860203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
    FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
    [No Abstract]   [Full Text] [Related]  

  • 49. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
    Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
    Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
    Allegra CJ; Boarman D
    Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the nature of permeability of sarcoma-180 cells to amethopterin in vitro.
    Hakala MT
    Biochim Biophys Acta; 1965 May; 102(1):210-25. PubMed ID: 5294407
    [No Abstract]   [Full Text] [Related]  

  • 52. Interaction of 1,N6-ethenoadenine derivatives of triphosphopyridine and reduced triphosphopyridine nucleotides with dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Biochemistry; 1976 Sep; 15(18):4042-7. PubMed ID: 9129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Phenotypic and genetic analysis of mutants resistant to amethopterin presenting a change in the anti-metabolite transport system].
    Trombe MC; Sicard AM
    C R Acad Hebd Seances Acad Sci D; 1973 Jun; 276(26):3495-8. PubMed ID: 4146851
    [No Abstract]   [Full Text] [Related]  

  • 55. Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin.
    Klingenberg O; Olsnes S
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):647-53. PubMed ID: 8573105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cells.
    Nichol CA
    Adv Enzyme Regul; 1968; 6():305-22. PubMed ID: 5756447
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetically alterable transport of amethopterin in Diplococcus pneumoniae. I. Physiological properties and kinetics of the wild-type system.
    Sirotnak FM; Sargent MG; Hutchison DJ
    J Bacteriol; 1967 Jan; 93(1):309-14. PubMed ID: 4381315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence of streptomycin-dependent mutations in a streptomycin-resistant culture of Diplococcus pneumoniae.
    Mishra AK; Ravin AW
    J Bacteriol; 1966 Mar; 91(3):1389. PubMed ID: 4379673
    [No Abstract]   [Full Text] [Related]  

  • 60. Correlation between molecular orbital distributions in drug-receptor interaction: Diels-Alder reaction systems and dihydrofolate reductase system.
    Kubodera H; Umeyama H
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4377-94. PubMed ID: 3442879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.